Explore
Trendline
Personalis Secures Medicare Coverage for Lung Cancer Surveillance, Reports Q1 Financial Results
Personalis Secures Medicare Coverage for Lung Cancer Surveillance, Reports Q1 Financial Results
Read More
Trendline
Caris Life Sciences Reports Significant Revenue Growth in First Quarter 2026
Caris Life Sciences Reports Significant Revenue Growth in First Quarter 2026
Read More
Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Read More
Trendline
Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance
Stevanato Group Reports 7% Revenue Growth in Q1 2026, Maintains Fiscal Guidance
Read More
Trendline
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in May 2026
Read More
Trendline
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Exelixis Reports Q1 2026 Financial Results and Announces New Drug Developments
Read More
Trendline
Verastem Oncology Reports Financial Results and Initiates New Cancer Trials
Verastem Oncology Reports Financial Results and Initiates New Cancer Trials
Read More
Trendline
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Vanda Pharmaceuticals Reports Q1 2026 Financial Results Highlighting Growth and New Product Launches
Read More
Trendline
GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook
GeneDx Reports Q1 2026 Financial Results, Adjusts Full-Year Revenue Outlook
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Nuvectis Pharma Reports Increased Net Loss in Q1 2026
Read More
Trendline
Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss
Supernus Pharmaceuticals Reports Q1 CY2026 Sales Surpassing Expectations Despite Earnings Miss
Read More
Trendline
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Nuvectis Pharma Reports Increased Net Loss in Q1 2026 Amid Clinical Expansion
Read More
